Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

BACKGROUND: Pulmonary infections caused by non-tuberculous mycobacteria (NTM) are hard to treat and have low cure rates despite intensive multidrug therapy. OBJECTIVES: To assess the feasibility of tedizolid, a new oxazolidinone, for the treatment of Mycobacterium avium and Mycobacterium abscessus....

Descripción completa

Detalles Bibliográficos
Autores principales: Ruth, Mike Marvin, Koeken, Valerie A C M, Pennings, Lian J, Svensson, Elin M, Wertheim, Heiman F L, Hoefsloot, Wouter, van Ingen, Jakko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021090/
https://www.ncbi.nlm.nih.gov/pubmed/31886864
http://dx.doi.org/10.1093/jac/dkz511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021090/
https://www.ncbi.nlm.nih.gov/pubmed/31886864
http://dx.doi.org/10.1093/jac/dkz511

Ejemplares similares